Overview

Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment

Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of Cipros 20 association in the treatment of dyslipidemia treatment.
Phase:
Phase 3
Details
Lead Sponsor:
EMS
Treatments:
Ciprofloxacin
Rosuvastatin Calcium